Brexit Bargains: 3 Clinical-Stage Biotechs to Buy

Brexit Bargains: 3 Clinical-Stage Biotechs to Buy


A global sell-off in stocks is causing companies with little exposure to the EU to drop. With key U.S. catalysts on deck, investors might want to scoop up shares in Novavax, Inc., Kite Pharma, and Flexion Therapeutics.



from Biotech News